Page last updated: 2024-09-04

benzamide adenine nucleotide and Precursor Cell Lymphoblastic Leukemia-Lymphoma

benzamide adenine nucleotide has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

*Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abali, EE; Banerjee, D; Bertino, JR; Felczak, K; Gounder, M; Johnson-Farley, N; Kerrigan, JE; Lin, H; Pankiewicz, KW; Roussel, B; Scotto, KW1

Other Studies

1 other study(ies) available for benzamide adenine nucleotide and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
A second target of benzamide riboside: dihydrofolate reductase.
    Cancer biology & therapy, 2012, Volume: 13, Issue:13

    Topics: Adenine Nucleotides; Benzamides; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Humans; IMP Dehydrogenase; Methotrexate; Molecular Targeted Therapy; NADP; Nucleosides; Phosphotransferases (Alcohol Group Acceptor); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tetrahydrofolate Dehydrogenase

2012